These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33512472)

  • 1. Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic".
    Khorshid M; AbdAllah M
    Inflamm Bowel Dis; 2021 Mar; 27(4):e39. PubMed ID: 33512472
    [No Abstract]   [Full Text] [Related]  

  • 2. Commenting on the Letter (Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic").
    Eltabbakh M; Abd Alaty W; Sakr MA; Sherief AF
    Inflamm Bowel Dis; 2021 Apr; 27(5):e66. PubMed ID: 33512507
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic.
    Eltabbakh MM; Shamkh MAA; Bassuny AN; Abd Alaty WH; Sakr MA; Sherief AF
    Inflamm Bowel Dis; 2020 Oct; 26(11):1771-1778. PubMed ID: 32860060
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 on the Nile: Review on the Management and Outcomes of the COVID-19 Pandemic in the Arab Republic of Egypt from February to August 2020.
    Gaye YE; Agbajogu C; El Oakley R
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33567519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
    Bekic D; Belosic Halle Z
    Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological Challenges for Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.
    Borghi L; Poli S; Furfaro F; Allocca M; Vegni EAM
    Psychosom Med; 2021 May; 83(4):397-398. PubMed ID: 33234778
    [No Abstract]   [Full Text] [Related]  

  • 7. Inflammatory Bowel Disease and the SARS-CoV-2 Pandemic: More Speed, Less Haste.
    Gower-Rousseau C; Fumery M; Pariente B;
    Gastroenterology; 2021 Jan; 160(1):473-474. PubMed ID: 32389663
    [No Abstract]   [Full Text] [Related]  

  • 8. Inflammatory Bowel Disease Management in a Major Referral Center During COVID-19 Pandemic.
    Garrido I; Lopes S; Macedo G
    Inflamm Bowel Dis; 2020 Sep; 26(10):e114-e115. PubMed ID: 32737966
    [No Abstract]   [Full Text] [Related]  

  • 9. Inflammatory Bowel Disease and COVID-19-"Preventive" Sick Certificates as a Frequent Coping Strategy in the Face of the Pandemic.
    Schlabitz F; Teich N; Michl P; Walldorf J
    Inflamm Bowel Dis; 2020 Aug; 26(9):e105-e106. PubMed ID: 32530027
    [No Abstract]   [Full Text] [Related]  

  • 10. The COVID-19 pandemic shows us in which way the care of patients with inflammatory bowel disease should move.
    Hernández Ramírez V; López Serrano P
    Rev Esp Enferm Dig; 2021 Feb; 113(2):153-154. PubMed ID: 33467860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of patients with inflammatory bowel disease and outcomes during the first wave of the Covid-19 pandemic.
    Viola A; Giambò F; Chiappetta MF; Costantino G; Pallio S; Fries W
    Dig Liver Dis; 2021 Jun; 53(6):689-690. PubMed ID: 33832871
    [No Abstract]   [Full Text] [Related]  

  • 12. Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic.
    Jena A; Kumar-M P; Singh AK; Sharma V
    Dig Liver Dis; 2021 Mar; 53(3):295-297. PubMed ID: 33132062
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective.
    Clough JN; Hill KL; Duff A; Sharma E; Ray S; Mawdsley JE; Anderson S; Irving PM; Samaan MA
    Inflamm Bowel Dis; 2020 Sep; 26(10):e125-e126. PubMed ID: 32592475
    [No Abstract]   [Full Text] [Related]  

  • 14. Balancing Risks and Benefits in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic.
    Kotze PG; Peyrin-Biroulet L; Danese S
    Gastroenterology; 2021 Jan; 160(1):472-473. PubMed ID: 32422207
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic Decisions in Inflammatory Bowel Disease in the SARS-Cov-2 Pandemic.
    Brain O; Satsangi J
    Gastroenterology; 2021 Apr; 160(5):1883-1884. PubMed ID: 32553759
    [No Abstract]   [Full Text] [Related]  

  • 16. Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.
    Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B
    Intern Med J; 2020 Jul; 50(7):798-804. PubMed ID: 32656985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of IBD Patients Who Are Unwilling or Unable to Receive Infusion Therapy During the COVID-19 Pandemic.
    Horrigan JM; Siegel CA; Tadros M
    Inflamm Bowel Dis; 2020 Oct; 26(11):e137. PubMed ID: 32737970
    [No Abstract]   [Full Text] [Related]  

  • 18. Establishing Safe Out-of-Hospital Infusion Centers May Improve the Quality of Care in Patients With IBD During the COVID-19 Pandemic.
    Behzad C; Taheri H; Kashifard M
    Inflamm Bowel Dis; 2020 Oct; 26(11):e140. PubMed ID: 32901275
    [No Abstract]   [Full Text] [Related]  

  • 19. The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem?
    Barberio B; Zingone F; Bertani L; Savarino E
    Gastroenterology; 2021 Apr; 160(5):1903-1904. PubMed ID: 32687929
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: IBD medications during the COVID-19 pandemic-are they safe to use?
    Fan D; Gearry RB
    Aliment Pharmacol Ther; 2021 Jul; 54(2):208-209. PubMed ID: 34170535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.